Home
|
Inbox
|
Search
|
Event
A42 - ILD SCIENTIFIC ABSTRACTS: TREATMENT AND ACUTE EXACERBATION
Location: ATS POSTER SESSION
Session Type: Thematic Poster Session
Sunday
May
20
9:15 AM
4:15 PM
Presentation(s)
- Prognostic Impact of the Early Physiological Response to Pirfenidone in Patients with Idio...
05-20-2018 11:15 AM - 1:00 PM - A Study of Tolerability and Therapeutic Effect of Antifibrotic Agents for Elderly Patients...
05-20-2018 11:15 AM - 1:00 PM - Synthetic Peptide dNP-15 Targeting TGF-Beta Signaling Prevents Pulmonary Fibrosis Induced ...
05-20-2018 11:15 AM - 1:00 PM - Nintedanib and Pirfenidone as a Bridge to Lung Transplant in Idiopathic Pulmonary Fibrosis...
05-20-2018 11:15 AM - 1:00 PM - Demonstration of Preclinical Efficacy in Pulmonary Fibrosis Models and of Clinical Safety,...
05-20-2018 11:15 AM - 1:00 PM - Weight Loss in Patients on Antifibrotic Therapy for IPF (Idiopathic Pulmonary Fibrosis): A...
05-20-2018 11:15 AM - 1:00 PM - Description and Predictors of Antifibrotic Medication Use Among Patients Enrolled in the P...
05-20-2018 11:15 AM - 1:00 PM - Indication for and Impact of Switching from Pirfenidone to Nintedanib in Idiopathic Pulmon...
05-20-2018 11:15 AM - 1:00 PM - Association of Angiotensin Modulators with the Course of Idiopathic Pulmonary Fibrosis [Bo...
05-20-2018 11:15 AM - 1:00 PM - Interstitial Pneumonia with Autoimmune Features and Histologic UIP: Anti-Fibrotic Versus I...
05-20-2018 11:15 AM - 1:00 PM - Risk Factors of Nausea or Anorexia Following Nintedanib Administration in Patients with Id...
05-20-2018 11:15 AM - 1:00 PM - Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF)...
05-20-2018 11:15 AM - 1:00 PM - Pirfenidone and Nintedanib Therapy for Idiopathic Pulmonary Fibrosis: A Tertiary Centre Ex...
05-20-2018 11:15 AM - 1:00 PM - PK and PK/PD Modeling to Inform Dosing Optimization for Pamrevlumab in Idiopathic Pulmonar...
05-20-2018 11:15 AM - 1:00 PM - Mycophenolate and Rituximab in Patients with Interstitial Lung Disease Associated with Con...
05-20-2018 11:15 AM - 1:00 PM - Pirfenidone in Patients with Unclassifiable Progressive Fibrosing Interstitial Lung Diseas...
05-20-2018 11:15 AM - 1:00 PM - Integrative Omics to Discover Drug Repurposing Candidates for Idiopathic Pulmonary Fibrosi...
05-20-2018 11:15 AM - 1:00 PM - Idiopathic Pulmonary Fibrosis (IPF) Drug Development Using SAMiRNA, a Second-Generation RN...
05-20-2018 11:15 AM - 1:00 PM - High-Flow Nasal Cannula Therapy for Acute Respiratory Failure in Patients with Interstitia...
05-20-2018 11:15 AM - 1:00 PM - Predictors in Patients with Fulminant Acute Exacerbation of Fibrosing Interstitial Pneumon...
05-20-2018 11:15 AM - 1:00 PM - INSTAGE: A Randomized Trial of Nintedanib Plus Sildenafil Versus Nintedanib Alone in Patie...
05-20-2018 11:15 AM - 1:00 PM - Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis...
05-20-2018 11:15 AM - 1:00 PM - Higher Body Mass Index Relates to Administering Pirfenidone for a Long-Term in Patients wi...
05-20-2018 11:15 AM - 1:00 PM - The Effectiveness, Safety and Tolerability of Pirfenidon Therapy Among Turkish Patients wi...
05-20-2018 11:15 AM - 1:00 PM - Investigating the Effect of Nintedanib on Changes in Biomarkers of ECM Turnover in Patient...
05-20-2018 11:15 AM - 1:00 PM - Effects of Nintedanib on Pulmonary Hypertension in IPF Patients [Board No. P1251]
05-20-2018 11:15 AM - 1:00 PM - Is It Useful to Use Neutrophil to Lymphocyte Ratio During Follow-Up and Response to Treatm...
05-20-2018 11:15 AM - 1:00 PM - Pharmacodynamics and Pharmacokinetics of the Autotaxin Inhibitor GLPG1690 in the FLORA Tri...
05-20-2018 11:15 AM - 1:00 PM - Gastrointestinal Adverse Events with Nintedanib with Add-On Pirfenidone in Patients with I...
05-20-2018 11:15 AM - 1:00 PM - Baseline Characteristics from a Pre-Specified Interim Analysis of a Phase IIb, Randomized,...
05-20-2018 11:15 AM - 1:00 PM - Efficacy of Oral Antifibrotic Agents in the Management of Combined Pulmonary Fibrosis and ...
05-20-2018 11:15 AM - 1:00 PM - Acute Exacerbation of Idiopathic Pulmonary Fibrosis Over a 9-Year Period in a Community Te...
05-20-2018 11:15 AM - 1:00 PM - Pharmacological Treatment for Acute Exacerbation of Fibrosing Interstitial Pneumonia: A Re...
05-20-2018 11:15 AM - 1:00 PM - The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis [Board No. P1...
05-20-2018 11:15 AM - 1:00 PM - Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Korea: Analysis of Risk Factors and...
05-20-2018 11:15 AM - 1:00 PM - Clinical Features of Acute Exacerbation of Interstitial Lung Disease Other than Idiopathic...
05-20-2018 11:15 AM - 1:00 PM - Correlation of Functional Assessment and CT Scores in Acute Exacerbations in Patients with...
05-20-2018 11:15 AM - 1:00 PM - Survival After Respiratory Hospitalization for Acute Exacerbation and Non-Acute Exacerbati...
05-20-2018 11:15 AM - 1:00 PM - Effects of Pirfenidone on Survival and Functional/Radiological Evolution in Patients with ...
05-20-2018 11:15 AM - 1:00 PM - The Addition of Antifibrotic Medications to Mycophenolate in the Treatment of Non-IPF Inte...
05-20-2018 11:15 AM - 1:00 PM - Facilitator
05-20-2018 11:15 AM - 1:00 PM - Facilitator
05-20-2018 11:15 AM - 1:00 PM - Facilitator
05-20-2018 11:15 AM - 1:00 PM
|
Home
|
Inbox
|
Search
|